DE69130576D1 - Impfstoffzusammensetzungen - Google Patents

Impfstoffzusammensetzungen

Info

Publication number
DE69130576D1
DE69130576D1 DE69130576T DE69130576T DE69130576D1 DE 69130576 D1 DE69130576 D1 DE 69130576D1 DE 69130576 T DE69130576 T DE 69130576T DE 69130576 T DE69130576 T DE 69130576T DE 69130576 D1 DE69130576 D1 DE 69130576D1
Authority
DE
Germany
Prior art keywords
vaccine compositions
compositions
immunoadjuvant
immunogen
activating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69130576T
Other languages
English (en)
Other versions
DE69130576T2 (de
Inventor
Christopher Penny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
North American Vaccine Inc
Original Assignee
North American Vaccine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by North American Vaccine Inc filed Critical North American Vaccine Inc
Publication of DE69130576D1 publication Critical patent/DE69130576D1/de
Application granted granted Critical
Publication of DE69130576T2 publication Critical patent/DE69130576T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69130576T 1990-05-07 1991-05-01 Impfstoffzusammensetzungen Expired - Fee Related DE69130576T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51846090A 1990-05-07 1990-05-07
PCT/CA1991/000144 WO1991016926A1 (en) 1990-05-07 1991-05-01 Vaccine compositions

Publications (2)

Publication Number Publication Date
DE69130576D1 true DE69130576D1 (de) 1999-01-14
DE69130576T2 DE69130576T2 (de) 1999-07-29

Family

ID=24064028

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69130576T Expired - Fee Related DE69130576T2 (de) 1990-05-07 1991-05-01 Impfstoffzusammensetzungen

Country Status (22)

Country Link
EP (1) EP0597838B1 (de)
JP (1) JPH05506234A (de)
CN (1) CN1056816A (de)
AT (1) ATE173936T1 (de)
AU (1) AU7777991A (de)
CA (1) CA2082425A1 (de)
CS (1) CS131891A3 (de)
DE (1) DE69130576T2 (de)
DK (1) DK0597838T3 (de)
ES (1) ES2124701T3 (de)
FI (1) FI925032A0 (de)
HR (1) HRP930658A2 (de)
HU (1) HUT65493A (de)
IE (1) IE911527A1 (de)
IL (1) IL97985A0 (de)
MX (1) MX172210B (de)
NO (1) NO924271L (de)
NZ (1) NZ238042A (de)
TW (1) TW221676B (de)
WO (1) WO1991016926A1 (de)
YU (1) YU79691A (de)
ZA (1) ZA913214B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY111880A (en) * 1992-03-27 2001-02-28 Smithkline Beecham Biologicals S A Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
AU3541495A (en) * 1994-09-01 1996-03-22 Wisconsin Alumni Research Foundation Therapeutic remodeling in aids
FR2726471B1 (fr) * 1994-11-07 1997-01-31 Pf Medicament Procede pour ameliorer l'immunogenicite d'un compose immunogene ou d'un haptene et application a la preparation de vaccins
US6027731A (en) * 1998-11-17 2000-02-22 Wisconsin Alumni Research Foundation Pertussis toxin induced lymphocytosis
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
JP2006502213A (ja) * 2002-10-10 2006-01-19 イエダ リサーチ アンド デベロップメント カンパニー リミテッド 脂肪族アルコール類の塩基性エステルおよび抗炎症薬または免疫調整薬としての使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1138773A (en) * 1979-04-18 1983-01-04 George Wojcik Synthetic adjuvants for stimulation of antigenic responses
US4639371A (en) * 1984-10-02 1987-01-27 New York Blood Center, Inc. Hepatitis B antigenic compositions and vaccines against hepatitis B derived therefrom
GB8807860D0 (en) * 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
NZ230424A (en) * 1988-08-25 1992-05-26 Liposome Co Inc Liposomal composition comprising an externally disposed antigen

Also Published As

Publication number Publication date
EP0597838A1 (de) 1994-05-25
HRP930658A2 (en) 1997-12-31
HU9203480D0 (en) 1993-01-28
NO924271D0 (no) 1992-11-06
MX172210B (es) 1993-12-07
TW221676B (de) 1994-03-11
FI925032A (fi) 1992-11-06
IE911527A1 (en) 1991-11-20
DK0597838T3 (da) 1999-08-16
EP0597838B1 (de) 1998-12-02
NZ238042A (en) 1993-12-23
CN1056816A (zh) 1991-12-11
ZA913214B (en) 1992-09-30
ATE173936T1 (de) 1998-12-15
JPH05506234A (ja) 1993-09-16
NO924271L (no) 1993-01-07
AU7777991A (en) 1991-11-27
WO1991016926A1 (en) 1991-11-14
YU79691A (sh) 1994-06-10
IL97985A0 (en) 1992-06-21
CA2082425A1 (en) 1991-11-08
FI925032A0 (fi) 1992-11-06
ES2124701T3 (es) 1999-02-16
DE69130576T2 (de) 1999-07-29
HUT65493A (en) 1994-06-28
CS131891A3 (en) 1992-02-19

Similar Documents

Publication Publication Date Title
NO930938D0 (no) Forbedrede vaksiner
DE3852761D1 (de) Saponin-hilfsmittel.
PL304419A1 (en) Urease based vaccine against heliobacter infections
ES2092306T3 (es) Adyuvante para vacunas.
DK0597838T3 (da) Vaccinesammensætninger
RU92016460A (ru) Вакцинная композиция, способ индукции иммунной реакции
KR930703006A (ko) 백신, 특히 돼지의 흉막폐염 백신의 면역강화

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee